Patrick Soderlund Unloaded $641,514 Worth of Electronic Arts Inc. (EA) Shares; Varian Medical Systems (VAR) Has 1.02 Sentiment

Varian Medical Systems, Inc. designs, makes, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company has market cap of $11.44 billion. It operates through two divisions, Oncology Systems and Imaging Components. It has a 93.81 P/E ratio. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

A few days ago, an insider trading sale was made. Patrick Soderlund, the EVP – EA Worldwide Studios and an insider of Electronic Arts Inc unloaded precisely 5,000 shares of Electronic Arts Inc, worth nearly $641,514 USD, at $128.3 for a share at the time of the sale. It seems he is very active lately as in the last month, he silently unloaded additional 5,000 shares of the company, worth $543,265 USD. Currently, Mr. Patrick, has in hand 51,871 shares, which accounts for 0.02% of Electronic Arts Inc’s market cap.

The stock decreased 2.85% or $3.65 during the last trading session, reaching $124.53. About 6.47 million shares traded or 58.29% up from the average. Electronic Arts Inc. (NASDAQ:EA) has risen 46.45% since February 3, 2017 and is uptrending. It has outperformed by 29.75% the S&P500.

Since August 10, 2017, it had 0 insider buys, and 25 insider sales for $27.37 million activity. LINZNER JOEL sold 4,000 shares worth $478,212. Soderlund Patrick sold 8,000 shares worth $944,324. The insider Jorgensen Blake J sold $1.18M. 10,058 Electronic Arts Inc. (NASDAQ:EA) shares with value of $1.19M were sold by Wilson Andrew. On Friday, October 20 the insider Schatz Jacob J. sold $113,600. Another trade for 200 shares valued at $21,170 was sold by Singh Vijayanthimala. $177,155 worth of stock was sold by Bruzzo Chris on Monday, October 2.

Among 27 analysts covering Electronic Arts (NASDAQ:EA), 24 have Buy rating, 0 Sell and 3 Hold. Therefore 89% are positive. Electronic Arts has $152 highest and $67 lowest target. $123.79’s average target is -0.59% below currents $124.53 stock price. Electronic Arts had 92 analyst reports since July 28, 2015 according to SRatingsIntel. As per Monday, December 18, the company rating was initiated by BTIG Research. The company was maintained on Wednesday, January 31 by Barclays Capital. The stock of Electronic Arts Inc. (NASDAQ:EA) has “Buy” rating given on Friday, July 28 by Wedbush. The rating was upgraded by Hilliard Lyons on Tuesday, February 9 to “Buy”. As per Monday, July 17, the company rating was maintained by Jefferies. The firm has “Buy” rating given on Monday, May 23 by Benchmark. The stock of Electronic Arts Inc. (NASDAQ:EA) has “Long-Term Buy” rating given on Wednesday, March 30 by Hilliard Lyons. The stock of Electronic Arts Inc. (NASDAQ:EA) has “Outperform” rating given on Friday, October 14 by Oppenheimer. The stock of Electronic Arts Inc. (NASDAQ:EA) earned “Buy” rating by KeyBanc Capital Markets on Sunday, November 19. The company was maintained on Friday, October 6 by Stifel Nicolaus.

Electronic Arts Inc. develops, markets, publishes, and distributes games, content, and services for game consoles, personal computers, mobile phones, and tablets worldwide. The company has market cap of $38.35 billion. It develops and publishes games primarily under the Battlefield, Mass Effect, Need for Speed, The Sims, and Plants v. It has a 38.84 P/E ratio. Zombies brands; and license games from others, such as FIFA, Madden NFL, and Star Wars, as well as publishes and distributes games developed by third parties.

Investors sentiment increased to 1.15 in 2017 Q3. Its up 0.12, from 1.03 in 2017Q2. It increased, as 35 investors sold Electronic Arts Inc. shares while 217 reduced holdings. 72 funds opened positions while 218 raised stakes. 281.04 million shares or 1.59% less from 285.59 million shares in 2017Q2 were reported. New York-based Cim Limited Liability Corporation has invested 0.24% in Electronic Arts Inc. (NASDAQ:EA). Friess Associate Ltd Limited Liability Company invested in 1.3% or 125,970 shares. Lenox Wealth Mngmt, Ohio-based fund reported 208 shares. 149,780 were accumulated by Retirement Sys Of Alabama. Appleton Incorporated Ma holds 0.22% or 11,205 shares in its portfolio. Commonwealth Of Pennsylvania School Empls Retrmt Systems holds 0.04% or 25,108 shares. Carnegie Capital Asset Management Limited Liability Corp reported 0.06% of its portfolio in Electronic Arts Inc. (NASDAQ:EA). Livforsakringsbolaget Skandia Omsesidigt invested 0.16% of its portfolio in Electronic Arts Inc. (NASDAQ:EA). 1.39M were accumulated by Ubs Asset Mgmt Americas. Mckinley Cap Management Ltd Liability Corporation Delaware has 3,735 shares. Dsm Capital Prtnrs Ltd Limited Liability Company invested 3.11% of its portfolio in Electronic Arts Inc. (NASDAQ:EA). Wetherby Asset Management stated it has 0.11% in Electronic Arts Inc. (NASDAQ:EA). Scout Invs reported 0.16% in Electronic Arts Inc. (NASDAQ:EA). Kames Public Limited holds 0.03% of its portfolio in Electronic Arts Inc. (NASDAQ:EA) for 10,286 shares. Yorktown & Co has 2,500 shares.

Lafleur & Godfrey Llc holds 3.47% of its portfolio in Varian Medical Systems, Inc. for 132,489 shares. Capital Counsel Llc Ny owns 325,993 shares or 2.92% of their US portfolio. Moreover, Fairpointe Capital Llc has 2.53% invested in the company for 1.28 million shares. The Alberta – Canada-based Qv Investors Inc. has invested 2.13% in the stock. Alecta Pensionsforsakring Omsesidigt, a Sweden-based fund reported 2.46 million shares.

The stock decreased 1.93% or $2.46 during the last trading session, reaching $124.86. About 692,185 shares traded. Varian Medical Systems, Inc. (VAR) has risen 29.46% since February 3, 2017 and is uptrending. It has outperformed by 12.76% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 16 insider sales for $16.73 million activity.

Ratings analysis reveals 50% of Varian Medical’s analysts are positive. Out of 2 Wall Street analysts rating Varian Medical, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $93.0 while the high is $98.0. The stock’s average target of $95.50 is -23.51% below today’s ($124.86) share price. VAR was included in 2 notes of analysts from January 23, 2017. RBC Capital Markets maintained it with “Sector Perform” rating and $93.0 target in Monday, January 23 report. Barrington Research maintained the stock with “Outperform” rating in Friday, January 27 report.